SHOULD BETA BLOCKERS STILL BE CONSIDERED SECOND LINE IN PATIENTS WITH SARS-COV-2

Detalles Bibliográficos
Autores principales: Tan, Samuel, Douen, Aaron, Sukhoo-Pertab, Marc L., Siu, Wenchy, Mondal, Avilash, Toreli, Aleksandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Cardiology Foundation. Published by Elsevier Inc. 2023
Materias:
Prevention and Health Promotion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983040/
http://dx.doi.org/10.1016/S0735-1097(23)02235-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983040/
http://dx.doi.org/10.1016/S0735-1097(23)02235-0

Ejemplares similares